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Summary
We have created a molecular switch by the in vitro recombination of nonhomologous genes and subjecting
the recombined genes to evolutionary pressure. The
gene encoding TEM1 ␤-lactamase was circularly permuted in a random fashion and subsequently randomly
inserted into the gene encoding Escherichia coli maltose binding protein. From this library, a switch (RG13)
was identified in which its ␤-lactam hydrolysis activity
was compromised in the absence of maltose but increased 25-fold in the presence of maltose. Upon removal of maltose, RG13’s catalytic activity returned to
its premaltose level, illustrating that the switching is reversible. The modularity of RG13 was demonstrated by
increasing maltose affinity while preserving switching
activity. RG13 gave rise to a novel cellular phenotype,
illustrating the potential of molecular switches to rewire the cellular circuitry.
Introduction
The incredible complexity of biological systems derives
to a large extent from the high degree of interactions
among their constituent components. As such, the cell
is often described as a complex circuit consisting of an
interacting network of molecules. A key component of
these networks are protein “switches” that serve to couple cellular functions. A switch recognizes an input signal (e.g., ligand concentration, pH, covalent modification), and, as a result, its output signal (e.g., enzyme
activity, ligand affinity, oligomeric state) is modified. Examples of natural switches include allosteric enzymes that
couple effector levels to enzymatic activity and liganddependent transcription factors that couple ligand concentration to gene expression. The ability to create novel
switches or to modify existing switches by coupling
hitherto uncoupled functions would enable the rewiring
of the cellular circuitry to our own design. In addition,
the ability to create protein switches has tremendous
practical potential for developing novel molecular sensors, “smart” materials, and as a tool for elucidating
molecular and cellular function.
We sought a general approach for creating switches
in which one could select from natural or engineered
proteins with the desired input and output functions
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and, by combining the proteins in a systematic fashion,
create switches in which their functions were tightly
coupled. In addition, we sought switches in which the
presence of the signal resulted in an increase in the
output function. Existing approaches [1–16] either require existing switches as starting points, are limited to
specific input functions and mechanisms, lack reversibility, or lack practicality in vitro or in vivo. In addition,
most existing approaches have not been shown to produce switches with large changes in output (⬎10-fold)
in response to a signal.
Our approach involves recombination between two
genes encoding the prerequisite input and output functions. Such an approach is inspired by the evolutionary
mechanism of domain recombination [17], a major facilitator in the natural evolution of protein function [18].
Domain recombination strategies have been applied to
the construction of switches [2, 7, 10–16], but the very
limited manner in which the domains were recombined
has restricted the success of this approach. We reasoned that a more diverse exploration of fusion geometries between two proteins would enable the creation of
switches with superior properties. The structural space
that we sought to explore can be conceptualized as
“rolling” the two proteins across each other’s surface
and fusing them through peptide bonds at the points
where their surfaces meet. We developed a homologyindependent, combinatorial method for recombining
genes that samples such a structural space. The method
involves two basic steps. First, the gene to be inserted is
circularly permuted in a random fashion to vary the fusion
site on the insert gene. Second, the library of the circularly
permuted gene is randomly inserted into the target gene.

Results and Discussion
We applied this approach to the recombination of the
genes encoding TEM-1 ␤-lactamase (BLA) and the
E. coli maltose binding protein (MBP). BLA and MBP
lack any sequence, structural, or functional relationship
except for the fact that they are periplasmic proteins
of bacterial origin. BLA is a monomeric enzyme that
hydrolyzes the amide bond of the ␤-lactam ring of
␤-lactam antibiotics. The presence of maltose has no
effect on wild-type BLA enzymatic activity, with or without the presence of an equimolar amount of MBP [15].
MBP is a member of the periplasmic binding protein
superfamily and is involved in chemotactic response
and the transport of maltodextrins. MBP consists of a
single polypeptide chain that folds into two domains
connected by a hinge region. The single binding site for
maltose is at the interface of these two domains. In
the absence of maltose, MBP exists in an open form.
Maltose binding is concomitant with a 35⬚ bending motion about the hinge, resulting in the closed form of the
protein [19]. We sought to create a molecular switch by
combining BLA and MBP in such a manner that the rate
of ␤-lactam hydrolysis was coupled to maltose binding
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Figure 1. Creation of MBP-BLA Molecular Switches by Nonhomologous Recombination
(A) The fragment of the BLA gene coding for the mature protein
(codons 24–286) is flanked by sequences coding for a GSGGG linker
(each of which contains a BamHI site). The fragment is excised by
digestion with BamHI and cyclized by ligation under dilute DNA
concentrations. A single, randomly located double-strand break is
introduced by DNaseI digestion to create the circularly permuted
library. This library is randomly inserted into plasmid pDIMC8-MBP
containing the MBP gene (malE) under control of the tac promoter
(tacP/O). The site for insertion in pDIMC8-MBP is created by introduction of a randomly located double-stranded break by digestion
with dilute concentrations of DNaseI.
(B) Sequence of switch. Regions derived from MBP are shown in
blue, and those from BLA are shown in red. The GSGGG linker and
a serine derived from the fusion of partial codons are shown in
black. The number in parentheses indicates the amino acid number
of the starting proteins. The numbering system for MBP does not
include the signal sequence. The numbering system for BLA does
include the signal sequence and does not follow the consensus
numbering system for ␤-lactamases.
(C) Structures of maltose-bound MBP [22] and BLA bound to an

and maltose concentration. We reasoned that in such
a switch the conformational change in the MBP domain
upon maltose binding would propagate to the active
site of the BLA domain and alter its catalytic properties,
a mechanism analogous to natural allosteric effects.
The fragment of the BLA gene coding for the mature
protein was circularly permuted in a random fashion
[20, 21] and subsequently randomly inserted [15] into a
plasmid containing the E. coli malE gene that codes for
MBP (Figure 1A). For the random circular permutation
of bla[24-286], we fused the 5⬘ and 3⬘ ends by an oligonucleotide sequence that would result in a GSGGG flexible
peptide linker between the original N and C termini of
the protein. This linker was designed to be of sufficient
length to connect the termini without perturbing BLA
structure. Statistical analysis on the resulting library indicated that a minimum of 27,000 members contained a
circularly permuted bla[24-286] inserted into malE in the
correct orientation with both fusion points in-frame with
malE. Approximately 0.33% of these members were able
to form colonies on rich media plates containing 200 g/
ml ampicillin and 50 mM maltose. These library members
were screened in 96-well format for a maltose dependence on ␤-lactamase activity using a colorimetric
assay for nitrocefin hydrolysis. We identified one protein
(RG13; Figure 1B) in which the initial velocity of nitrocefin
hydrolysis (at 50 M nitrocefin) increased by 17-fold in
the presence of maltose. In RG13, the BLA was circularly
permuted in a loop that precedes a ␤ sheet that lines
the active site of the enzyme. The circular-permuted
BLA was inserted at the beginning of an ␣ helix of MBP
such that two MBP residues were deleted (Figure 1C).
Using purified RG13, we confirmed that the increase
in catalytic activity occurred only in the presence of
sugars that are known to bind and induce a conformational change in MBP (Figure 2A). Sugars known to
induce a large conformational change [22] (maltose
and maltotriose; 35⬚ closure angle) produced a 15- to
20-fold increase in the rate of nitrocefin hydrolysis.
␤-cyclodextrin, which only induces a 10⬚ hinge bending
motion in MBP [24], increased the rate 2-fold. Nonligands such as sucrose, lactose, and galactose had no
effect. We next determined that the switching was reversible (i.e., upon removing maltose, the activity returns
to its premaltose level). This was demonstrated both
by competing maltose off RG13 using ␤-cyclodextrin
(Figure 2B) and by subjecting RG13 to repeated rounds
of dialysis and addition of maltose to cycle between low
and high levels of enzymatic activity (Figure 2C). This
reversibility is one of the features that differentiates our
approach from methods such as conditional protein
splicing [8, 16], which produce nonreversible switches
that control the production of active protein rather than
a protein’s activity per se.
From steady-state kinetics experiments, we determined RG13’s Michaelis-Menten parameters for nitrocefin hydrolysis at 25⬚C in the absence and presence

active-site inhibitor [23] oriented such that the fusion sites in RG13
are proximal. Dark blue, MBP[1-316]; yellow, BLA[227-286]; white,
GSGGG linker; red, BLA[24-226]; green, MBP[319-370]; light blue,
MBP deleted residues 317 and 318.
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Figure 3. Characterization of Switches

Figure 2. Switch Activity in RG13 Is Specific to Ligands of MBP and
Is Reversible
(A) The percent increase in the initial velocity of nitrocefin hydrolysis
at 20 M nitrocefin upon addition 5 mM of the indicated ligands
(maltose, maltotriose, and ␤-cyclodextrin) and nonligands (sucrose,
lactose, and galactose).
(B) Reversible switching using competing ligand. During the enzymatic hydrolysis of nitrocefin, formation of product is monitored by
absorbance at 486 nm. At time zero, the reaction is started in 2 ml
phosphate buffer (0.1 M) with 20 M nitrocefin and 2.5 nM RG13.
At the time indicated by the first arrow, 20 l of 1 M maltose was
added, resulting in a 10-fold increase in the reaction rate. This maltose concentration is above the Kd for maltose but is subsaturating.
At the time indicated by the second arrow, 230 l of 10 mM
␤-cyclodextrin was added (final concentrations are 1.0 mM
␤-cyclodextrin and 8.9 M maltose). Because RG13 has similar affinities for maltose and ␤-cyclodextrin but ␤-cyclodextrin is present at
a ⬎100-fold higher concentration, the ␤-cyclodextrin preferentially
replaces the maltose bound to RG13, and the rate of reaction decreases to a level consistent with ␤-cyclodextrin’s modest effect
on nitrocefin hydrolysis.
(C) Reversible switching after dialysis. The initial rate of nitrocefin
hydrolysis at 25 M nitrocefin was measured at the indicated steps.
Maltose was added to a final concentration of 5 mM.

of maltose. In the absence of maltose, the catalytic constants were kcat ⫽ 200 ⫾ 40 s⫺1 and Km ⫽ 550 ⫾ 120
M. With the addition of saturating amounts of maltose,
kcat increased 3-fold and Km decreased 8-fold, resulting
in a 25-fold increase in kcat/Km. The kinetic constants of
RG13 in the presence of saturating concentrations of
maltose (kcat ⫽ 620 ⫾ 60 s⫺1 and Km ⫽ 68 ⫾ 4 M) were
comparable to that previously reported for BLA at 24⬚C
(kcat ⫽ 900 s⫺1 and Km ⫽ 110 M; [25]), indicating that
RG13 is a very active TEM1 ␤-lactamase in the presence
of maltose. RG13 has exhibited switching behavior with
all seven BLA substrates tested to date, including ampicillin (16-fold rate increase at 50 M ampicillin) and carbenicillin (12-fold rate increase at 50 M carbenicillin).
The increase in kcat indicates that maltose binding affects the catalytic steps. However, since Km is a combination of the rate constants for substrate binding as

(A) Dissociation constants for maltose were determined in the absence (white bars) and presence (black bars) of saturating concentrations of carbenicillin. The apparent dissociation constants in the
presence of subsaturating concentrations (25 M) of nitrocefin (gray
bars) were also determined. The dissociation constants for maltose
of MBP, MBP(I329W), and MBP(I329W/A96W) (dashed line) reported
by Marvin and Hellinga [28] are shown for comparison.
(B–D) Steady-state kinetic parameters of nitrocefin hydrolysis for
RG13, RG13(I329W), and RG13(I329W/A96W) in the presence (black
bars) or absence (white bars) of saturating concentrations of maltose. Experimental conditions were as follows: 100 mM sodium phosphate buffer (pH 7.0), 25⬚C.

well as catalysis [26], Km could not be directly used to
ascertain the effect of maltose on substrate binding.
Instead, the effect of maltose on substrate binding was
determined indirectly by measuring the effect of substrate on maltose binding using intrinsic protein fluorescence. These studies suggested that RG13 undergoes
a conformational change much like MBP does upon
maltodextrin binding, since maltose-induced quenching
of total fluorescence (ⵑ10%) and shifting of the maximum fluorescence wavelength (a 1.5 nm red-shift for
maltose and a 4 nm blue-shift for ␤-cyclodextrin) were
similar to that previously reported for MBP [27]. The
presence of saturating amounts of the substrate carbenicillin decreased the dissociation constant of maltose
and RG13 from 5.5 ⫾ 0.5 M to 1.3 ⫾ 0.5 M; thus,
maltose binding must decrease the dissociation constant of carbenicillin and RG13 by the same factor (Supplemental Figure S1). This corresponds to a coupling
energy of approximately 1 kcal/mol and offers an additional explanation for the increase in ␤-lactam hydrolysis
in the presence of maltose: a positive heterotropic allosteric effect on substrate binding.
Presumably, the BLA domain of the apo, open form
of RG13 exists in a compromised, less active conformation. In the ligand-bound state, the BLA domain exists
in a more normal, active conformation. But what is the
state of the BLA domain in the process of closing? At
what closure angle do the catalytic properties of RG13
improve? To address these questions, we took advantage of mutations in the hinge region of MBP that manip-
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Table 1. Ampicillin Resistance of E. coli Cells in the Presence
and Absence of Maltose

Expressed
Protein
None
RG13
BLA(W208G)b
BLA

Minimum Inhibitory Concentration
of Ampicillin (g/ml)a
No Maltose

50 M Maltose

4
128
32
ⱖ2000

4
512
32
ⱖ2000

a

Conditions: DH5␣-E cells on LB plates (with or without maltose)
incubated at 37⬚C for 20 hr.
b
A mutant of BLA with reduced activity.

ulate the conformational equilibria between the open
and closed state [28]. Residual dipolar couplings have
been used to establish that the apo forms of these mutants are partially closed relative to the apo wild-type
MBP with the ensemble average closure angles being
9.5⬚ and 28.4⬚ for I329W and I329W/A96W, respectively
[29]. The ligand-bound closed forms of MBP, MBP
(I329W) and MBP(I329W/A96W), have closure angles of
35⬚. Partial closing shifts the equilibrium toward the ligand-bound state, and thus the mutations increase the
affinity for maltose [28].
Introduction of these mutations into RG13 resulted in
the creation of more sensitive switches, switches that
respond to lower concentrations of maltose (Figures 3A
and 3B). The fact that we observed qualitatively similar
changes in maltose affinity when the mutations are introduced into RG13 strongly suggests that the relative order and magnitude of the angles of closure of RG13,
RG13(I329W), and RG13(I329W/A96W) are similar to that
of MBP, MBP(I329W), and MBP(I329W/A96W). Thus, the
apo forms of the two RG13 mutants offer conformations
intermediate between the open to the closed form of
RG13, conformations that may reflect that of RG13 in
the process of closing. Assuming that the process of
closing in RG13 passes through the conformations of
the apo forms of the two RG13 mutants, kinetic characterization of RG13(I329W) and RG13(I329W/A96W) suggested that the initial stages of closing do not result
in changes in the BLA domain that substantially affect
catalysis (Figures 3B–3D). Both kcat and Km improved
during the intermediate stages of closing, but the majority of the effect on Km occurred during the final stages
of closing.
As the magnitude of the allosteric effect was on the
same order as that of many natural allosteric enzymes,
we next examined the biological effects of RG13. The
switching activity was sufficient to result in an observable phenotype: maltose-dependent resistance to ampicillin (Table 1). E. coli cells expressing RG13 had a minimum inhibitory concentration (MIC) for ampicillin that
was 4-fold higher in the presence of 50 M maltose.
In contrast, the addition of the same concentration of
sucrose or glucose to a plate did not affect the MIC.
Thus, RG13 serves to couple the previously unrelated
functions of ampicillin resistance and maltose concentration. E. coli cells expressing RG13 function as a
growth/no growth sensor for maltose.

Significance
We have shown that two unrelated proteins can be
systematically recombined in order to link their respective functions and create molecular switches. A
combination of random circular permutation and random domain insertion enabled the creation of a MBPBLA fusion geometry in which conformational changes
induced upon maltose binding could propagate to the
active site of BLA and increase BLA enzymatic activity
up to 25-fold. The functional coupling of two proteins
with no evolutionary or functional relationship is a
powerful strategy for engineering novel molecular
function. For example, coupling a ligand binding protein and a protein with good signal transduction properties would result in the creation of a molecular sensor for the ligand. Furthermore, switches that establish
connections between cellular components with no
previous relationship can result in novel cellular circuitry and phenotypes. We envision, for example, that
such switches might establish connections between
molecular signatures of disease (e.g., abnormal concentrations of proteins, metabolites, signaling, or
other molecules) and functions that serve to treat the
disease (e.g., delivery of drugs, modulation of signaling
pathways, or modulation of gene expression) and
therefore possess selective therapeutic properties.
Supplemental Data
Supplemental Data including Experimental Procedures and a figure
are available at http://www.chembiol.com/cgi/content/full/11/11/
1483/DC1/.
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